Renaissance Technologies (RenTech)'s BLTE Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 52,000 shares of Belite Bio, Inc (BLTE) worth $8.29 M, representing 0.01% of the portfolio. First purchased in 2023-Q4, this short-term holding has been held for 6 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in BLTE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 52,000 shares. Largest reduction occurred in Q1 2024, reducing 4,900 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Belite Bio (BLTE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Belite Bio (BLTE) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +52,000 | New Buy | 52,000 | $159.44 |
| Q4 2025 | -2,812 | Sold Out | 0 | $0.00 |
| Q3 2025 | -1,488 | Reduce 34.60% | 2,812 | $74.00 |
| Q2 2025 | +4,300 | New Buy | 4,300 | $57.70 |
| Q1 2024 | -4,900 | Sold Out | 0 | $0.00 |
| Q4 2023 | +4,900 | New Buy | 4,900 | $45.71 |
Renaissance Technologies (RenTech)'s Belite Bio Investment FAQs
Renaissance Technologies (RenTech) first purchased Belite Bio, Inc (BLTE) in Q4 2023, acquiring 4,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Belite Bio, Inc (BLTE) for 6 quarters since Q4 2023.
Renaissance Technologies (RenTech)'s largest addition to Belite Bio, Inc (BLTE) was in Q1 2026, adding 52,000 shares worth $8.29 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 52,000 shares of Belite Bio, Inc (BLTE), valued at approximately $8.29 M.
As of the Q1 2026 filing, Belite Bio, Inc (BLTE) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Belite Bio, Inc (BLTE) was 52,000 shares, as reported at the end of Q1 2026.